Wealth Alliance Raises Holdings in Haleon plc (NYSE:HLN)

Wealth Alliance grew its position in shares of Haleon plc (NYSE:HLN) by 14.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,823 shares of the company’s stock after buying an additional 4,883 shares during the period. Wealth Alliance’s holdings in Haleon were worth $320,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Washington Trust Advisors Inc. raised its stake in shares of Haleon by 353.3% during the 3rd quarter. Washington Trust Advisors Inc. now owns 2,960 shares of the company’s stock valued at $25,000 after purchasing an additional 2,307 shares during the period. CoreFirst Bank & Trust bought a new stake in shares of Haleon during the 4th quarter valued at $26,000. Barclays PLC raised its stake in shares of Haleon by 56.4% during the 2nd quarter. Barclays PLC now owns 3,317 shares of the company’s stock valued at $28,000 after purchasing an additional 1,196 shares during the period. Resurgent Financial Advisors LLC bought a new stake in shares of Haleon during the 4th quarter valued at $29,000. Finally, Clearstead Advisors LLC bought a new stake in shares of Haleon during the 3rd quarter valued at $32,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on HLN shares. Argus reiterated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th. HSBC initiated coverage on Haleon in a research note on Wednesday. They set a “buy” rating on the stock. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Haleon Price Performance

Shares of NYSE HLN opened at $8.12 on Friday. The firm has a market capitalization of $37.08 billion, a P/E ratio of 29.00, a P/E/G ratio of 2.12 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The stock’s 50-day simple moving average is $8.30 and its two-hundred day simple moving average is $8.29. Haleon plc has a twelve month low of $7.70 and a twelve month high of $9.05.

Haleon Dividend Announcement

The firm also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Shareholders of record on Friday, March 15th will be paid a $0.1064 dividend. The ex-dividend date is Thursday, March 14th. This represents a yield of 1.8%. Haleon’s dividend payout ratio is currently 75.00%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.